International Clinical Trial: Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07454031) titled 'Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma' on March 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Peking University

Condition: Peritoneal (Metastatic) Cancer

Intervention: Drug: intraperitoneal PX in combination with nab-paclitaxel

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 15, 2026

Target Sample Size: 22

To know more, visit https://clinicaltrials.gov/study/N...